Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Alzheimer's review completed

The expected High Court Judicial Review of the Alzheimer's drugs guidance produced by the National Institute for Health and Clinical Excellence (NICE) is complete. The BBC and PharmaTimes have reported the findings of the review.

A press release (PDF) on the NICE reveals that the guidance was supported in five of the six areas that were challenged.

The rulings in the six areas were as follows:

  • Benefits to carers were considered
  • Long term care costs were accurately calculated
  • Procedural fairness was not breached by providing a 'read-only' economic model
  • Concluding that there is no cumulative benefit after six months treatment was not irrational
  • Consideration of the AD 2000 study was not irrational
  • NICE failed in its duties by not offering guidance specific to certain patient groups, namely those with learning difficulties or whose first language is not English

NICE has been asked to clarify the guidance within 28 days in respect of ensuring equal access for people with learning difficulties or whose first language is not English. NICE have undertaken to comply fully with this ruling.

Action: Clinicians who prescribe treatments for Alzheimer's disease can now feel confident in fully implementing the current NICE guidance.

Share 'Alzheimer's review completed' on Email Share 'Alzheimer's review completed' on Delicious Share 'Alzheimer's review completed' on Digg Share 'Alzheimer's review completed' on Facebook Share 'Alzheimer's review completed' on Google+ Share 'Alzheimer's review completed' on reddit Share 'Alzheimer's review completed' on StumbleUpon Share 'Alzheimer's review completed' on Twitter

atomic-wealth

2 Comments to “Alzheimer's review completed”

  1. [...] had earlier been supported in five of the six areas that were challenged and were only required to amend one area of the [...]

    Pingback by Prescribing Advice For GPs » NICE Should Be More Transparent — May 1, 2008 #
    Reply

  2. […] The National Institute of Health and Clinical Excellence (NICE) has issued revised guidance for Alzheimer's disease following the outcome of the recent judicial review. […]

    Pingback by NICE Issue Amended Alzheimer’s Advice | Prescribing Advice For GPs — September 11, 2007 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer